Your browser doesn't support javascript.
loading
Prognostic significance of a complement factor H autoantibody in early stage NSCLC.
Gottlin, Elizabeth B; Campa, Michael J; Gandhi, Rikesh; Bushey, Ryan T; Herndon Nd, James E; Patz, Edward F.
Affiliation
  • Gottlin EB; Department of Radiology, Duke University Medical Center, Durham, NC, USA.
  • Campa MJ; Department of Radiology, Duke University Medical Center, Durham, NC, USA.
  • Gandhi R; Department of Radiology, Duke University Medical Center, Durham, NC, USA.
  • Bushey RT; Department of Orthopaedic Surgery, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Herndon Nd JE; Department of Radiology, Duke University Medical Center, Durham, NC, USA.
  • Patz EF; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC, USA.
Cancer Biomark ; 34(3): 385-392, 2022.
Article in En | MEDLINE | ID: mdl-35068447
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Cancer Biomark Journal subject: BIOQUIMICA / NEOPLASIAS Year: 2022 Document type: Article Affiliation country: United States Country of publication: Netherlands
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Cancer Biomark Journal subject: BIOQUIMICA / NEOPLASIAS Year: 2022 Document type: Article Affiliation country: United States Country of publication: Netherlands